Mangalam Drugs and Organics Ltd - MANGALAM DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE584F01014
₹ 101.75 (0.10%) icon24 Apr, 2024, 12:00:00 AM
Open
₹ 102.20
Prev. Close
₹ 101.65
Turnover(lac)
₹ 0.00
Day's High
₹ 103.40
Day's Low
₹ 101.40
52 Wk High
₹ 132.45
52 Wk Low
₹ 90.80
Book Value
₹ 88.05
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 161.05
P/E
0.00
EPS
0.00
Div. Yield
0.00

Mangalam Drugs and Organics Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/24/2024 12:00:00 AM

    ₹ 101.75 0.10 0.10
  • Open
  • ₹ 102.2
  • Prev. Close
  • ₹ 101.65
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 103.4
  • Day's Low
  • ₹ 101.4
  • 52 Week's High
  • ₹ 132.45
  • 52 Week's Low
  • ₹ 90.8
  • Book Value
  • ₹ 88.05
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 161.05
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Mangalam Drugs and Organics Ltd Corporate Actions

08 Mar , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

06 Feb , 2024

12:00 AM

31 Oct , 2023

12:00 AM

31 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

18 Sep , 2023

12:00 AM

AGM

Announcement date: 18 Sep , 2023

View Details

03 Aug , 2023

12:00 AM

03 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

No Record Found


Mangalam Drugs and Organics Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Mangalam Drugs and Organics Ltd SHAREHOLDING SNAPSHOT
25 April , 2024 | 03:02 AM

PROMOTER - TOTAL50.32%

Indian: 50.32%

Foreign: 0%

NON-PROMOTER - TOTAL 49.68%

Institutions: 0.26%

Non-Institutions: 49.42%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Mangalam Drugs and Organics Ltd FINANCIALS

No Data Available To Display Chart

Mangalam Drugs and Organics Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Mangalam Drugs and Organics Ltd

  • Govardhan M Dhoot
  • Chairman & Managing Director
  • Brijmohan Dhoot
  • Whole-time Director
  • Rukmesh P. Dhandhania
  • Independent Director
  • Nidhi S. Mundada
  • Independent Director
  • Praveen Saxena
  • Independent Director
  • Jayant Barde
  • Company Sec. & Compli. Officer
  • Rakesh K. Milwani
  • Director

Summary

Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001. The company was promoted by Dhoot family. The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals.The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra. They also have an in-house Research and Development (R&D) Base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, and dyes and intermediaries.In April 1, 1996 three other group companies, namely Mangalam Organics Pvt Ltd, Shree Mangalam Pharma Pvt Ltd and Mangalam Rasayan Pvt Ltd were amalgamated with the company. In the year 1999, the company launched a new product namely, Nimesulide. In the year 2001, they launched two new products namely Amodiaquine Hydrochloride and Amodiaquine. In the year 2003-2004, the bulk drug production capacity of the Company was increased from 350 MTPA to 600 MTPA. During... Read More


Reports by Mangalam Drugs and Organics Ltd


Reports by Mangalam Drugs and Organics Ltd

Company FAQ

No Record Found